RVX_logo_RGB.jpg
Resverlogix和EVERSANA宣布合作以支持即将在美国和加拿大启动的Apabetalone初始商业化
June 04, 2021 09:17 ET | Resverlogix Corp
阿尔伯塔省卡尔加里和芝加哥, June 04, 2021 (GLOBE NEWSWIRE) -- Resverlogix...
RVX_logo_RGB.jpg
Resverlogix 與 EVERSANA 宣佈建立合作夥伴關係,以支持用於治療 2019 冠狀病毒病的 apabetalone 在美國和加拿大的初期商業化活動
June 04, 2021 09:17 ET | Resverlogix Corp
亞伯達省卡加利和芝加哥, June 04, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. (Resverlogix) (TSX:RVX) 與全球生命科學行業下一代商業服務的先驅 EVERSANA™ 今天宣佈建立合作夥伴關係,以支持 apabetalone 計劃在美國和加拿大(已授權對用於治療 2019 冠狀病毒病的 apabetalone...
RVX_logo_RGB.jpg
Resverlogix and EVERSANA Announce Partnership to Support the Pending Launch of the Initial Commercialization of Apabetalone for COVID-19 in the United States and Canada
June 03, 2021 08:04 ET | Resverlogix Corp
CALGARY, Alberta and CHICAGO, June 03, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) and EVERSANA™, the pioneer of next generation commercial services to the global life...
RVX_logo_RGB.jpg
Resverlogix Announces US$6 Million Debenture Financing
May 05, 2021 10:01 ET | Resverlogix Corp
CALGARY, Alberta, May 05, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX) today announces that it has entered into an investment agreement with a subsidiary of...
Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease
April 27, 2021 13:41 ET | Resverlogix Corp
CALGARY, Alberta, April 27, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today the recent publication of an article titled: “Effect of Apabetalone...
RVX_logo_RGB.jpg
Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
April 20, 2021 08:00 ET | Resverlogix Corp
CALGARY, Alberta, April 20, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today the publishing of an article titled: “Bromodomain and extraterminal protein...
RVX_logo_RGB.jpg
加拿大卫生部授权Resverlogix立即开始Apabetalone治疗新冠肺炎的临床研究
April 12, 2021 09:06 ET | Resverlogix Corp
阿尔伯塔省卡尔加里, April 12, 2021 (GLOBE NEWSWIRE) -- Resverlogix...
RVX_logo_RGB.jpg
加拿大衛生部向 Resverlogix 發出授權以開始對 Apabetalone 進行 2019 冠狀病毒病的即時臨床研究
April 12, 2021 09:06 ET | Resverlogix Corp
亞伯達省卡加利, April 12, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp.(「Resverlogix」)(TSX:RVX) 欣然宣佈已成功收到加拿大衛生部的「不反對書」。當局已批准 apabetalone 的 2019 冠狀病毒病臨床試驗申請。計劃的第 2 期試驗將是一項開放標籤研究、評估口服 apabetalone 的安全性和療效,以及結合...
RVX_logo_RGB.jpg
Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
April 12, 2021 08:00 ET | Resverlogix Corp
CALGARY, Alberta, April 12, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce that it has successfully received its desired “No Objection Letter” from...
RVX_logo_RGB.jpg
Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
March 17, 2021 08:00 ET | Resverlogix Corp
CALGARY, Alberta, March 17, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today the publishing of an article, titled: “BET Inhibition Blocks Inflammation-Induced...